performed univariate Cox regression analysis to evaluate the clinical prognostic values of m6A RNA methylation regulators in glioblastoma (GBM), and revealed that HNRNPC, ALKBH5, and ZC3H13 are favorable prognostic markers, whereas FTO is an unfavorable prognostic marker for GBM. Here, HNRNPC is linked to glioblastoma.